Circulation Reports最新文献_第3页

Impact of Atrial Fibrillation Triggers on Long-Term Outcomes of a Second Catheter Ablation of Nonparoxysmal Atrial Fibrillation 心房颤动触发因素对非阵发性心房颤动第二次导管消融术长期疗效的影响

Circulation Reports Pub Date : 2024-02-03 DOI: 10.1253/circrep.cr-23-0069

Masaya Shinohara, Tadashi Fujino, R. Wada, Shintaro Yao, Kensuke Yano, Katsuya Akitsu, Hideki Koike, Toshio Kinoshita, Hitomi Yuzawa, Takanori Ikeda

引用次数: 0

Content 内容

Circulation Reports Pub Date : 2023-12-08 DOI: 10.1253/circrep.cr-5-content12

引用次数: 0

Content 内容

Circulation Reports Pub Date : 2023-11-10 DOI: 10.1253/circrep.cr-5-content11

引用次数: 0

Preprocedural Controlling Nutritional Status Score as a Predictor of Mortality in Patients Undergoing Transcatheter Mitral Valve Repair ― A Single Center Experience in Japan ― 术前控制营养状态评分作为经导管二尖瓣修复患者死亡率的预测因子-日本单中心经验

Circulation Reports Pub Date : 2023-11-02 DOI: 10.1253/circrep.cr-23-0055

Airi Noda, Shunichi Doi, Shingo Kuwata, Noriko Shiokawa, Norio Suzuki, Yoko Kanamitsu, Yukio Sato, Shoji Tatsuro, Taishi Okuno, Takahiko Kai, Masashi Koga, Yasuhiro Tanabe, Masaki Izumo, Yuki Ishibashi, Yoshihiro J Akashi

引用次数: 0

Content 内容

Circulation Reports Pub Date : 2023-10-10 DOI: 10.1253/circrep.cr-5-content10

引用次数: 0

CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing. 勘误:对依多沙班和利伐沙班剂量与血浆浓度监测在非瓣膜性房颤中的安全性和有效性进行再评估:与标签上和标签外剂量的观察。

Circulation Reports Pub Date : 2023-09-08 DOI: 10.1253/circrep.CR-66-0012

Michihiro Suwa, Yuki Nohara, Isao Morii, Masaya Kino

引用次数: 0

Feasibility of Catheter Ablation for Biatrial Tachycardia Using Multiple Catheters via an Atrial Shunt Device. 经心房分流器多导管导管消融治疗双房性心动过速的可行性。

Circulation Reports Pub Date : 2023-09-08 DOI: 10.1253/circrep.CR-23-0052

Satoshi Oka, Yusuke Watanabe, Masashi Amano, Tsukasa Kamakura, Chisato Izumi, Kengo Kusano

引用次数: 0

Feasibility of Transcatheter Aortic Valve Implantation in Patients With Very Severe Aortic Stenosis. 经导管主动脉瓣植入术治疗严重主动脉瓣狭窄的可行性。

Circulation Reports Pub Date : 2023-09-08 DOI: 10.1253/circrep.CR-23-0063

Yoshikuni Kobayashi, Masaki Izumo, Kazuaki Okuyama, Nina Uenomachi, Tatsuro Shoji, Takahiko Kai, Taishi Okuno, Yukio Sato, Shingo Kuwata, Masashi Koga, Yuki Ishibashi, Yasuhiro Tanabe, Takeshi Miyairi, Yoshihiro J Akashi

{"title":"Feasibility of Transcatheter Aortic Valve Implantation in Patients With Very Severe Aortic Stenosis.","authors":"Yoshikuni Kobayashi, Masaki Izumo, Kazuaki Okuyama, Nina Uenomachi, Tatsuro Shoji, Takahiko Kai, Taishi Okuno, Yukio Sato, Shingo Kuwata, Masashi Koga, Yuki Ishibashi, Yasuhiro Tanabe, Takeshi Miyairi, Yoshihiro J Akashi","doi":"10.1253/circrep.CR-23-0063","DOIUrl":"https://doi.org/10.1253/circrep.CR-23-0063","url":null,"abstract":"Background: Very severe aortic stenosis (AS) has a poor prognosis even in asymptomatic patients, and asymptomatic very severe AS is a Class IIa indication for aortic valve replacement, although the safety and effectiveness of transcatheter aortic valve implantation (TAVI) for very severe AS is not well-established. Methods and Results: This study included 366 patients undergoing TAVI at a single center, with 85 and 281 patients in the very severe AS (peak velocity ≥5 m/s or mean pressure gradient (PG) ≥60 mmHg) and severe AS groups, respectively. Procedural and clinical outcomes at 1-year follow-up were compared between groups. The calcium scores were significantly higher in the very severe AS group (2,864.5 vs. 1,405.8 arbitrary units [AU] (P<0.001). Although the patient-prosthesis mismatch rate was higher in the very severe AS group (38.3% vs. 25.7%; P=0.029), there was no significant difference in the early safety and clinical efficacy between the groups (16.5% vs. 17.1% and 12.0% vs. 18.9%, respectively). Similarly, there was no significant difference in all-cause mortality at 1 year (4.8% vs. 9.8%). Conclusions: Despite a higher incidence of prosthesis-patient mismatch in those with very severe AS, the procedural and clinical outcomes were comparable to those in patients with severe AS. TAVI may be a reasonable treatment option for very severe AS.","PeriodicalId":10276,"journal":{"name":"Circulation Reports","volume":"5 9","pages":"358-364"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/b2/circrep-5-358.PMC10483111.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10225159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rapid Fatal Progression and Autopsy Findings of Effusive-Constrictive Pericarditis With Hypertrophic Cardiomyopathy. 积液性缩窄性心包炎合并肥厚性心肌病的快速致死性进展和尸检结果。

Circulation Reports Pub Date : 2023-09-08 DOI: 10.1253/circrep.CR-23-0061

Takashi Hiruma, Tatsuya Murai, Masahiro Watanabe, Mamoru Nanasato, Morimasa Takayama, Mitsuaki Isobe

{"title":"Rapid Fatal Progression and Autopsy Findings of Effusive-Constrictive Pericarditis With Hypertrophic Cardiomyopathy.","authors":"Takashi Hiruma, Tatsuya Murai, Masahiro Watanabe, Mamoru Nanasato, Morimasa Takayama, Mitsuaki Isobe","doi":"10.1253/circrep.CR-23-0061","DOIUrl":"https://doi.org/10.1253/circrep.CR-23-0061","url":null,"abstract":"patient underwent subxiphoid pericardiocentesis, with 700 mL exudate drained; however, the constrictive echocardiographic findings persisted. The patient remained hemodynamically unstable and eventually died due to multi-organ dysfunction on Day 10 of hospitalization. The autopsy revealed cardiomegaly (heart weight 550 g) and a thickened pericardium (Figure E,F). Myocardial hypertrophy with disarray and interstitial fibrosis was observed, but no other cardiomyopathies were indicated. Notably, both the visceral and parietal pericardium had inflammatory cell infiltration and fibrous thickening (Figure G,H). There was no evidence of infection, autoimmune disease, or maligA 68-year-old man with hypertrophic cardiomyopathy (HCM), chronic atrial fibrillation, and prior pacemaker implantation (at 50 years of age) was referred to the Sakakibara Heart Institute complaining of dyspnea. Computed tomography and transthoracic echocardiography showed significant circumferential pericardial effusion (Figure A,B). The heart presented a swinging motion (Supplementary Movie). The early diastolic mitral flow velocity presented inspiratory decrease and expiratory increase. Furthermore, the early diastolic mitral septal annular velocity (e’) was increased compared with lateral e’, indicating constriction of the heart (Figure C,D). The","PeriodicalId":10276,"journal":{"name":"Circulation Reports","volume":"5 9","pages":"365-366"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/45/48/circrep-5-365.PMC10483110.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10225161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Use of Oral Opioid Therapy for Dyspnea in Patients With Advanced Heart Failure　- A Single-Center Retrospective Study. 口服阿片类药物治疗晚期心力衰竭患者呼吸困难的临床应用-一项单中心回顾性研究

Circulation Reports Pub Date : 2023-09-08 DOI: 10.1253/circrep.CR-23-0059

Tomohiro Nakamura, Mari Nakamura, Mayumi Kai, Yumiko Shibasaki, Haruki Tomita, Miku Watabe, Hatsumi Yokokura, Shin-Ichi Momomura

{"title":"Clinical Use of Oral Opioid Therapy for Dyspnea in Patients With Advanced Heart Failure　- A Single-Center Retrospective Study.","authors":"Tomohiro Nakamura, Mari Nakamura, Mayumi Kai, Yumiko Shibasaki, Haruki Tomita, Miku Watabe, Hatsumi Yokokura, Shin-Ichi Momomura","doi":"10.1253/circrep.CR-23-0059","DOIUrl":"https://doi.org/10.1253/circrep.CR-23-0059","url":null,"abstract":"Background: For patients with advanced heart failure, palliative care, including opioids, is needed as a treatment for refractory dyspnea. However, little evidence has been reported on the efficacy and safety of opioids, and their use is not well established. Methods and Results: We have introduced a protocol for the use of opioids for dyspnea in patients with advanced heart failure admitted to Saitama Citizens Medical Center. Following this protocol, differences in clinical variables and outcome were investigated between patients in whom opioids were initiated intravenously or subcutaneously (i.v./s.c. group; n=13) and patients in whom they were initiated orally (oral group; n=18). In a comparison of baseline characteristics, significantly more patients in the oral group had a history of hospitalization for heart failure within the past year, and significantly more patients were treated with dobutamine and tolvaptan. After initiation of opioid treatment, both groups showed improvement in dyspnea; however, serial changes in vital signs were significantly greater in the i.v./s.c. group. The survival rate was significantly higher in the oral group (P<0.0001), with 33% of patients discharged alive. Conclusions: The clinical use of oral opioids using a single-center protocol is reported, suggesting that oral opioids may be practical and effective for dyspnea in patients with advanced heart failure.","PeriodicalId":10276,"journal":{"name":"Circulation Reports","volume":"5 9","pages":"351-357"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/45/circrep-5-351.PMC10483112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10225158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0